Acme Universal Safezone 9 Ltd. Sets October 30 Results Meeting

Acme Universal Safezone 9 Ltd. has scheduled a board meeting for October 30, 2026, to consider its Q2 and first-half FY2027 results and appoint a new registrar and transfer agent. The safety-footwear maker recently received an international order worth ₹0.7018 crore, to be executed by December 2026.

What will Acme Universal Safezone 9's board consider on October 30?

Acme Universal Safezone 9's board is scheduled to meet on Friday, October 30, 2026, according to an October 24 BSE intimation. The agenda includes approval of the company's financial results for the second quarter and first half of FY2027. The meeting is also expected to consider the appointment of a new registrar and transfer agent, or RTA.

The date listed as the upcoming earnings date is also October 30. No Q2 FY2027 revenue, profit, margin, or earnings-per-share figures were included in the supplied information. Investors will therefore need to wait for the board-approved disclosure for the reported financial performance during the quarter and six-month period.

The company is listed on the BSE under scrip code 544964 and has ISIN INE1KUL01020. It operates in the footwear sector and manufactures and supplies industrial safety footwear under the ACME brand.

What is the significance of the new international safety-shoe order?

Acme Universal Safezone 9 received an international order worth ₹0.7018 crore for specialised safety shoes on October 22, with execution scheduled by December 2026. The order is a disclosed business development ahead of the October 30 board meeting, but the available information does not state the buyer, destination market, volumes, or the order's expected effect on profitability.

The order amount is modest relative to the company's reported FY2026 revenue from operations of ₹205.9031 crore. Still, it provides a defined delivery milestone in the current financial year and confirms an overseas order for the company's specialised footwear range. Its financial recognition will depend on execution and the company's applicable accounting policies, neither of which was detailed in the supplied data.

How did Acme Universal Safezone 9 perform in FY2026?

Acme Universal Safezone 9 reported revenue from operations of ₹205.9031 crore for the year ended March 31, 2026, compared with ₹187.3558 crore in FY2025. This represents stated growth of 9.90%. The company reported profit after tax of ₹5.8573 crore in FY2026, up from ₹0.8042 crore a year earlier.

The supplied company profile stated that net profit margin increased to 2.84% in FY2026 from 0.43% in FY2025. Equity capital was reported at ₹14.03 crore for the year ended March 31, 2026. These figures provide the most detailed annual operating and profit data available ahead of the scheduled Q2 and H1 FY2027 disclosure.

A separate annual-results table in the supplied material lists rounded FY2026 sales of ₹204 crore and net profit of negative ₹5 crore. That conflicts with the more detailed company-profile figures above, which report FY2026 PAT of ₹5.8573 crore. The October 30 results disclosure may provide investors with updated information that helps clarify the reported financial position and trend.

How has Acme Universal Safezone 9's shareholding and stock moved?

Acme Universal Safezone 9's promoter holding was reported to have declined to 69.73% in the October 2026 quarter from 94.88%. The supplied information does not specify the transactions or reasons behind this change. A material shift in promoter ownership is relevant for investors because it changes the proportion of shares held outside the promoter group.

The stock was quoted at ₹106.05, up ₹0.05 or 0.05%, in data dated October 26, 2026. It was stated to be 14.75% below its 52-week high. The same data set reported returns of 13.86% over one month, three months, year to date, and one year, while the figures should be read alongside the different quote dates contained in the supplied market information.

The company was listed on October 6, 2026, according to the announcement record. Its market performance is therefore being assessed over a short listed-history period. The forthcoming financial results and any details provided on the order execution could be relevant disclosures for shareholders following the recent listing.

Why do the October disclosures matter for the footwear business?

Acme Universal Safezone 9's business is focused on industrial safety footwear rather than general consumer footwear. For such a manufacturer, revenue growth, operating profitability, order fulfilment and customer mix are relevant operating markers. The disclosed international order adds a specific near-term delivery commitment, while the results meeting is expected to provide the next formal update on financial performance.

The planned RTA appointment is also part of the board agenda. Registrar and transfer agents support shareholder recordkeeping and securities-related investor services. The supplied announcement does not identify the proposed appointee or provide reasons for the planned appointment, so those details remain pending board consideration or subsequent disclosure.

Conclusion

The October 30 board meeting is the immediate event for Acme Universal Safezone 9 shareholders because it is scheduled to consider Q2 and H1 FY2027 results alongside an RTA appointment. The company enters the meeting after reporting FY2026 revenue growth of 9.90% and disclosing a ₹0.7018 crore international order for specialised safety shoes.

Investors will watch for the board-approved quarterly and half-year figures, details on the RTA appointment, and any update on execution of the international order by December 2026. They may also look for disclosures that clarify the inconsistency between the detailed FY2026 profit figure in the company profile and the separate annual-results table provided in the source material.